We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How veterinary medicines can be advertised.
How to register with an NHS doctor and patient questionnaires in Ukrainian and Russian.
Applying for an individual domestic drugs licence to prescribe cocaine, diamorphine and dipipanone for the treatment of addiction.
How to account for VAT on goods and services provided by registered health professionals, including doctors, dentists, nurses and pharmacists.
Information for patients, healthcare professionals and developers of new medicines
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Report of the review of the evidence for dependence on, and withdrawal from, prescribed medicines.
This study was carried out in 80 public health facilities across 12 districts in 2 states of Haryana and Punjab
Advice for healthcare professionals on the reclassification of codeine linctus to a prescription-only medicine (POM), following a public consultation.
Information for companies on the import and export of controlled drugs to and from the UK.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Falsified, potentially harmful Ozempic▼ and Saxenda products have been found in the UK.
An investigation by the Criminal Enforcement Unit (CEU) of the Medicines and Healthcare products Regulatory Agency (MHRA) has led to charges being brought against five people from the Wolverhampton area for the illegal supply of prescription-only medicines and controlled drugs.
Three men have been sentenced to a total of three years at Manchester Crown Court after pleading guilty to the illegal sale and supply online of prescription-only medicines and controlled Class B and Class C drugs with a street value...
It's illegal to drive if you're unfit to do so because you're on legal or illegal drugs, or you have certain levels of drugs or medicine in your blood
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.